BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
1-Year Return 36.47%
This Quarter Return
-15.26%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.26B
AUM Growth
-$351M
Cap. Flow
+$59.1M
Cap. Flow %
4.69%
Top 10 Hldgs %
73.34%
Holding
36
New
3
Increased
5
Reduced
4
Closed
2

Top Buys

1
EQRX
EQRx, Inc. Common Stock
EQRX
+$68.2M
2
XLO icon
Xilio Therapeutics
XLO
+$44.9M
3
MRSN icon
Mersana Therapeutics
MRSN
+$10.5M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$9.94M
5
TSVT
2seventy bio
TSVT
+$4.6M

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$62.1M
2
AVIR icon
Atea Pharmaceuticals
AVIR
+$10.9M
3
IVVD icon
Invivyd
IVVD
+$3.99M
4
BLUE
bluebird bio
BLUE
+$2.92M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$2.49M

Sector Composition

1 Healthcare 95.4%
2 Financials 3.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XFOR icon
26
X4 Pharmaceuticals
XFOR
$73.2M
$6.61M 0.52%
96,218
+25,567
+36% +$1.76M
BLUE
27
DELISTED
bluebird bio
BLUE
$5.38M 0.43%
26,909
-14,638
-35% -$2.92M
PANA
28
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$4.85M 0.38%
500,000
– –
ARYE
29
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$4.85M 0.38%
500,000
– –
BLSA
30
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$4.78M 0.38%
487,500
– –
TSVT
31
DELISTED
2seventy bio
TSVT
$4.6M 0.36%
+179,393
New +$4.6M
OMEG
32
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$3.91M 0.31%
400,000
– –
FLACU
33
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$2.98M 0.24%
300,000
– –
JYAC
34
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$2.93M 0.23%
300,000
– –
MLTX icon
35
MoonLake Immunotherapeutics
MLTX
$3.34B
– –
-250,000
Closed -$2.49M
DRNA
36
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-3,080,237
Closed -$62.1M
1
2